Article info
PDFCorrespondence response
Response to ‘To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic’ by Parperis
- Correspondence to Dr Francesca Romana Spinelli, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari - Reumatologia, Sapienza University of Rome, Roma 00161, Italy; francescaromana.spinelli{at}uniroma1.it
Citation
Response to ‘To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic’ by Parperis
Publication history
- Received April 22, 2020
- Accepted April 22, 2020
- First published May 4, 2020.
Online issue publication
December 14, 2020
Article Versions
- Previous version (4 May 2020).
- Previous version (23 May 2020).
- You are viewing the most recent version of this article.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage